Alex Braun
Head of Investor Relations
Replay available
Acumen Pharmaceuticals, Inc. (ABOS) Q1 2026 Earnings Call
Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) Q1 2026 earnings conference call, held 2026-05-12. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Matt Zuga
CFO and Chief Business Officer
Pete Stravopoulos
Analyst, Cantor Fitzgerald
Jim Doherty
President and Chief Development Officer
Mary-Kate Davis
Analyst, Citi
Eric Siemers
Chief Medical Officer
Emily Tice
Analyst, CFO
Jason Szymanski
Analyst, Bank of America
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Acumen Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.117 Good day and thank you for standing by. Welcome to the Acumen Pharma first quarter 00:00:05.117 -- 00:00:08.502 2026 conference call and webcast. 00:00:08.502 -- 00:00:12.267 At this time, all participants are in a listen-only mode. 00:00:12.267 -- 00:00:15.951 After the speaker's presentation, there will be a question and answer session. 00:00:15.951 -- 00:00:21.078 To ask a question during the session, you will need to press star 11 on 00:00:21.078 -- 00:00:26.625 your telephone. You will then hear an automated message advising your hand is raised. 00:00:26.625 -- 00:00:30.305 To withdraw your question, please press star 11 again. 00:00:30.305 -- 00:00:33.409 Please be advised that today's conference is being recorded. 00:00:33.409 -- 00:00:38.835 I would now like to hand the conference over to your first speaker today, Alex Braun, 00:00:38.835 -- 00:00:42.780 Head of Investor Relations. Please go ahead. 00:00:42.780 -- 00:00:47.185 Thanks, Didi. Good morning and welcome to the Acumen Conference Call to discuss our business 00:00:47.185 -- 00:00:52.111 update and financial results for the quarter ended March 31st, 2026. 00:00:52.111 -- 00:00:56.477 With me today are Dan O'Connell, our Chief Executive Officer, and Matt Zuga, our CFO 00:00:56.477 -- 00:01:00.456 and Chief Business Officer. They will have brief prepared remarks, and then we'll open 00:01:00.456 -- 00:01:04.000 the call for questions. Joining for the Q&A session, we also have Dr. 00:01:04.000 -- 00:01:07.205 Jim Doherty, our President and Chief Development Officer, and Dr. 00:01:07.205 -- 00:01:09.969 Eric Siemers, our Chief Medical Officer. 00:01:09.969 -- 00:01:14.014 Before we begin, we encourage listeners to go to the Investors section of the Acumen 00:01:14.014 ...